Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PIPAC with Cisplatin and Doxorubicin in Gastric Cancer
NCT01854255Phase 2Completed
- Sponsor
- Ruhr University Bochum
- Start
- Nov 2013
- Primary completion
- Oct 2016
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of cisplatin, doxorubicin in gastric cancer (GC), peritoneal carcinomatosis (PC), sponsored by Ruhr University Bochum. Started Nov 2013; status: completed.
02
Drugs
cisplatindoxorubicin
03
Conditions
gastric cancer (GC)peritoneal carcinomatosis (PC)
Beyond the preview
Go deeper on NCT01854255.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01854255.